ARTICLE | Company News
North American Vaccine news
May 22, 1995 7:00 AM UTC
NVX completed construction of its 25,000 square foot manufacturing plant. The facility will produce the Beltsville, Md., company's DTaP vaccine to prevent diphtheria, tetanus and pertussis. ...